KO

원료의약품

Ketoconazole (케토코나졸)

KDMF APIs

Ketoconazole

Ketoconazole 기본 정보

품목명 (한글)

케토코나졸

분류

외피

CAS No.

65277-42-1

KDMF 등록번호

20190111-167-I-565-06

제조원

Zhejiang East-Asia Phamaceutical Co.,Ltd

규격

USP

품목 정보

Ketoconazole 품목 정보

IUPAC Name

1-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one

Description

Ketoconazole is an imidazole antifungal agent used in the prevention and treatment of a variety of fungal infections. Label It functions by preventing the synthesis of ergosterol, the fungal equivalent of cholesterol, thereby increasing membrane fluidity and preventing growth of the fungus. 5 , 11 Ketoconazole was first approved in an oral formulation for systemic use by the FDA in 1981. 9 At this time it was considered a significant improvement over previous antifungals, miconazole and clotrimazole , due to its broad spectrum and good absorption. However, it was discovered that ketoconazole produces frequent gastrointestinal side effects and dose-related hepatitis. 9 , 10 These effects combined with waning efficacy led to its eventual replacement by triazole agents, fluconazole , itraconazole , [voraconazole], and posaconazole . Ketoconazole and its predecessor clotrimazole continue to be used in topical formulations.

Certificate of Analysis

If you need more information, please contact us

규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신드립니다. (02-579-1056 · ace@acebiopharm.com)